Group 1 - The core viewpoint of the article highlights that 康龙化成 (Crown Bioscience) is experiencing a decline in stock price, dropping over 3% to HKD 22.12, with a trading volume of HKD 113 million [2] - On January 15, 康龙化成 announced a plan to place nearly 58.44 million new H-shares at a price of HKD 22.82 per share, representing an approximate 8.5% discount to the closing price on January 14, aiming to raise a net amount of about HKD 1.319 billion [2] - Approximately 70% of the funds raised will be allocated to project construction to enhance laboratory service facilities, drug process development, and production capacity [2] Group 2 - 康龙化成 recently released an earnings forecast, projecting a net profit attributable to shareholders for 2025 to be between HKD 1.614 billion and HKD 1.686 billion, reflecting a decrease of 6% to 10% compared to the previous year [2] - During the reporting period, the company's operating revenue is expected to grow by 13% to 16%, while the net profit after excluding non-recurring gains and losses is anticipated to increase by 36% to 41% year-on-year [2]

每经AI快讯，康龙化成(03759.HK)再跌超3%，截至发稿跌3.41%，报22.12港元，成交额1.13亿港元。 ...

Core Viewpoint - Kanglong Chemical (03759) has seen a decline of over 3%, currently trading at HKD 22.12, with a transaction volume of HKD 113 million [1] Group 1: Fundraising and Stock Issuance - On January 15, Kanglong Chemical announced a plan to issue nearly 58.44 million new H-shares at a price of HKD 22.82 per share, representing a discount of approximately 8.5% compared to the closing price on January 14 [1] - The net proceeds from this fundraising are expected to be around HKD 1.319 billion, with approximately 70% allocated for project construction to enhance laboratory service facilities, drug process development, and production capacity [1] Group 2: Earnings Forecast - Kanglong Chemical recently released an earnings forecast, projecting a net profit attributable to shareholders for 2025 to be between HKD 1.614 billion and HKD 1.686 billion, indicating a year-on-year decline of 6% to 10% [1] - During the reporting period, the company's operating revenue is expected to grow by 13% to 16%, while the net profit after excluding non-recurring gains and losses is anticipated to increase by 36% to 41% year-on-year [1]

消息面上，1月15日，康龙化成发布公告，拟配售近5844.08万股新H股，配售价每股22.82港元，较1月 14日收市价折让约8.5%，募资所得款项净额约13.19亿港元，其中约70%将用于公司的项目建设，以加 强实验室服务设施、药物工艺开发及生产设施的能力及产能。 康龙化成（300759）(03759)再跌超3%，截至发稿，跌3.41%，报22.12港元，成交额1.13亿港元。 此外，康龙化成近日公布业绩预告，预计2025年归属于上市公司股东的净利润为16.14亿元-16.86亿元， 比上年同期下降6%-10%。报告期内，公司营业收入同比增长13%-16%，扣除非经常性损益后的净利润 同比增长36%-41%。 ...

Group 1 - The stock of Kanglong Chemical (03759.HK) has dropped over 3%, currently down 3.44% at HKD 23.04 [2] - The trading volume reached HKD 157 million [2]

Core Viewpoint - Kanglong Chemical (03759) has seen a decline of over 3%, currently trading at HKD 23.04 with a transaction volume of HKD 157 million [1] Group 1: Company Announcement - Kanglong Chemical announced a proposed placement of approximately 58.44 million new H-shares, representing about 3.19% of the company's enlarged total issued shares and approximately 16.57% of the total issued H-shares [1] - The placement price is set at HKD 22.82 per share, reflecting a discount of approximately 8.5% compared to the closing price on January 14 [1] Group 2: Use of Proceeds - The company expects total gross proceeds and net proceeds from the placement to be approximately HKD 1.334 billion and HKD 1.319 billion, respectively [1] - Approximately 70% of the proceeds will be used for project construction to enhance laboratory service facilities, drug process development, and production capacity [1] - About 10% of the proceeds will be allocated to repay bank loans and other borrowings to optimize the capital structure, while the remaining 20% will be used to supplement working capital and for other general purposes [1]

Core Viewpoint - 康龙化成 announced a placement of approximately 58.44 million new H-shares, representing about 3.19% of the company's expanded total issued shares and about 16.57% of the total issued H-shares, at a price of HKD 22.82 per share, which is an 8.5% discount compared to the closing price on January 14 [1] Group 1 - The company’s stock fell by 3.44% to HKD 23.04, with a trading volume of HKD 157 million [1] - The expected total amount raised from the placement is approximately HKD 13.34 billion, with a net amount of about HKD 13.19 billion [1] - Approximately 70% of the proceeds will be used for project construction to enhance laboratory service facilities, drug process development, and production capacity [1] Group 2 - About 10% of the proceeds will be allocated to repay bank loans and other borrowings to optimize the capital structure [1] - The remaining 20% will be used to supplement working capital and for other general purposes [1]

Group 1 - The top short-selling ratios are led by China Resources Beer (100.00%), Lenovo Group (95.24%), and JD Health (94.15%) [1] - The highest short-selling amounts are recorded for Alibaba (3.923 billion), Tencent Holdings (2.552 billion), and Trip.com Group (1.172 billion) [1][2] - Meituan, Kanglong Chemical, and Haitong Securities have the highest deviation values at 55.33%, 50.16%, and 48.65% respectively [1] Group 2 - The top ten short-selling ratios include China Resources Beer (100.00%), Lenovo Group (95.24%), and JD Health (94.15%) with respective amounts of 11,700, 7,019,200, and 150,000 [2] - The top ten short-selling amounts show Alibaba at 39.23 billion, Tencent at 25.52 billion, and Trip.com at 11.72 billion with respective short-selling ratios of 17.78%, 15.59%, and 7.41% [2] - The top ten deviation values highlight Meituan (55.33%), Kanglong Chemical (50.16%), and Haitong Securities (48.65%) with their respective short-selling amounts [2]

Core Viewpoint - Kanglong Chemical announced the approval of a proposal to issue new H-shares based on general authorization during the 18th meeting of its third board of directors [1] Group 1 - The board meeting was held on January 15 [1] - The proposal aims to enhance the company's capital structure and support future growth [1]

Market Overview - The Hang Seng Index fell by 0.55%, down 149 points, closing at 26,850 points, while the Hang Seng Tech Index dropped by 1.83% [1] - The trading volume in the Hong Kong stock market reached HKD 163.9 billion in the morning session [1] Company Highlights - Jiexin International Resources (03858) rose over 5%, reaching a new high as black tungsten ore prices surpassed 500,000 yuan, prompting several tungsten companies to raise long-term contract prices [1] - Likin Resources (02245) increased by over 10% due to disruptions in Indonesian nickel ore quotas, while Zhongwei New Materials (02579) gained over 9% [1] - China Rare Earth Holdings (03788) experienced significant volatility, rising by 8% after announcing the termination of its spin-off listing plan and plans to rename itself "Rare Earth Gold" [1] - Ocean Park Hong Kong (02255) surged over 10%, with visitor numbers on the first day of the New Year holiday increasing by 60% year-on-year [1] - Zhipu (02513) rose over 4% after announcing a collaboration with Huawei to open-source a new generation image generation model [1] - China Heartland Fertilizer (01866) increased by over 4%, anticipating a potential global urea supply shortage, and has been actively repurchasing shares [1] - Woan Robotics (06600) gained over 7% following the release of its humanoid intelligent robot, Onero [1] - Jiantao Laminates (01888) saw a nearly 6% increase after announcing a price hike, which is expected to become a trend in the copper-clad laminate industry [1] - Qiu Tai Technology (01478) declined over 7% as Citigroup reported that the company's net profit last year fell below expectations [1] Other Notable Movements - Kanglong Chemical (03759) dropped over 5% after announcing a placement of shares at an 8.5% discount, aiming to raise nearly HKD 1.32 billion [2] - Trip.com Group (09961) plummeted over 19% due to an investigation by the State Administration for Market Regulation for alleged monopoly practices, while Same City Travel (00780) fell over 11% [2]